Metoprolol Tartrate ER (WW) Pellets
Rraynex supplies Metoprolol Tartrate ER (WW) Pellets as extended-release pellets in the Beta Blocker category, in a strength of 9%.
Product overview
Metoprolol is a cardioselective beta-blocker used for hypertension, angina and heart failure; extended-release forms allow once-daily dosing.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Formulation and release profile
Extended-release (ER) pellets prolong drug release over many hours so that a single daily or twice-daily dose maintains therapeutic levels.
Pharmaceutical applications
- Capsule filling of metoprolol tartrate er (ww) pellets for cardiovascular products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Metoprolol Tartrate ER (WW) Pellets
- Form
- extended-release Pellets
- Therapeutic category
- Beta Blocker
- Strength
- 9%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Metoprolol Tartrate ER (WW) Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities